Cervical Cancer Screening Market is set to exhibit expansion at over 7% CAGR through 2031 - States Fact.MR

Increase in awareness among females regarding the severity of cervical diseases, across regions, is leading to rising demand for cervical dysplasia diagnostics.

As such, there has been a rise in requirement from various end users such as hospitals, diagnostic centers, and ambulatory surgical centers.

To get in-depth information view the report - https://www.factmr.com/report/cervical-dysplasia-diagnostics-market

According to a report titled “High Rates of High-Grade Cervical Dysplasia In High-Risk Young Women With Low-Grade Cervical Cytology”, published by the National Center for Biotechnology Information (NCBI) on 6th January 2020, in the past 50 years, incidence and mortality from cervical cancer in industrialized countries has decreased by half because of the introduction of Pap Smear as a screening test.

However, cervical cancer is still an exceedingly common cause of death in developing countries.

According to Fact.MR, the global cervical dysplasia diagnostics market is expected to expand at over 7% CAGR during the forecast period of 2021 to 2031.

To Know the COVID-19 Impact on Europe Region, Request for Sample - https://www.factmr.com/connectus/sample?flag=S&rep_id=5564

Key Takeaways from Study

Rise in requirement for diagnostic tests to be witnessed
Increase in demand from hospitals to fuel sales
The United States to lead demand for cervical dysplasia diagnostics

Asia Pacific market to register most promising growth rate, with its epicenters in China and India
Some other lucrative regions attracting stakeholders are Germany, Canada, the United Kingdom, and France

“Rise in requirement for various diagnostic tests such as Pap Test and Bimanual Pelvic Examination, to name a few, is catering to the growth of manufacturers providing cervical dysplasia diagnostics,” says a Fact.MR analyst.

Increase in Awareness Regarding Severity of Cervical Diseases Boosting Market Growth

While initiatives taken by various organizations are helping in spreading awareness among women about cervical diseases, diverse categories of products launched by manufacturers are further propelling growth in this industry.

According to a report published by NCBI in 2020, despite the decrease, cervical cancer remains problematic in industrialized countries, with a 2017 estimate of 12,820 new cases and 4,210 deaths in the United States alone.

Share Your Requirements & Get Customized Reports - https://www.factmr.com/connectus/sample?flag=RC&rep_id=5564

As stated in the report, more than 60% of new cases developed in women who were unscreened.

Who is Winning in this Space?

The global cervical dysplasia diagnostics market remains competitive in nature, making it tougher for key players to sail through the cutthroat competition.

As a result, key market players are focusing on developing a broader range of products to capitalize on growing opportunities.

For instance,Cooper Surgical launched its new range of products, such as Cervical Cell Collection Device Papette® Sterile, Cervical Cell Collection Device Rovers® Cervex-Brush®, and others, during the last few years.

Quest Diagnostics Inc. launched its new set of products, such as CytoComplete™ Solutions, for integrated, streamlined results for Pap and HPV, and others, a couple of years back.

Buy Now for Exclusive Analyst Support - https://www.factmr.com/checkout/5564/S

More Valuable Insights

In its latest report, Fact.MR offers unbiased analysis of the global cervical dysplasia diagnostics market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031.

In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (diagnostic tests and diagnostic devices) and end user (hospitals, diagnostic centres, private gynaecologist offices, research & academic institutes, and ambulatory surgical centres), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Visit Our Website - https://www.factmr.com/
Content Source - https://www.factmr.com/media-release/1841/global-cervical-dysplasia-diagnostics-market

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.